Alzheimer disease trials in Australia

In Australia 19 Also abroad 816

19 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
InRAD Observational Study
Where
Melbourne
Age
18 years and over
People
50,000 worldwide
Run by
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
See details and how to joinNCT07213700
Phase 2Taking people
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
Where
Ivanhoe, Macquarie Park, Melbourne
Age
55 years to 85 years
People
160 worldwide
Run by
Sanofi
See details and how to joinNCT07688213 · EU 2025-524581-14-00
Phase 3Taking people
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
Where
Camperdown, Macquarie Park
Age
55 years to 80 years
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07717411
Phase 2Taking people
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
Where
Camperdown, Parkville
Age
50 years to 90 years
People
450 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07781657 · EU 2026-526158-14-00
Phase 1Taking people
A Study of LY3439539 in Participants With Alzheimer's Disease
Where
Adelaide, Ivanhoe, Kogarah, Macquarie University, Melbourne
Age
50 years to 85 years
People
30 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07598370
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Where
Carlton, Darlinghurst, Kogarah, Macquarie Park, Perth
Age
60 years to 85 years
People
586 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06976216 · EU 2025-520746-30-00
Phase 2Taking people
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Where
Ivanhoe, Kogarah, Macquarie Park, Malvern
Age
50 years to 85 years
People
340 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07033494 · EU 2024-519190-19-00
Phase 3Taking people
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Where
Bedford Park, Box Hill, Camperdown, Darlinghurst, Heidelberg, Kogarah, Macquarie Park, Melbourne, Parkville, Woodville
Age
50 years to 90 years
People
80,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07177352
No phaseTaking people
Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis
Where
Box Hill, Wantirna
Age
18 years and over
People
1,000
Run by
Monash University
See details and how to joinNCT06339190
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Where
Birtinya, Herston (rbwh Grounds), Ivanhoe, Southport
Age
60 years to 85 years
People
586 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06976203 · EU 2025-520747-32-00
Phase 2Taking people
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Where
Darlinghurst, Daw Park, Macquarie Park, Nedlands
Age
55 years to 90 years
People
120 worldwide
Run by
Celgene
See details and how to joinNCT06808984
No phaseTaking people
Dominantly Inherited Alzheimer Network (DIAN)
Where
Melbourne, Perth, Sydney
Age
18 years and over
People
700 worldwide
Run by
Washington University School of Medicine
See details and how to joinNCT00869817
Phase 2/3Taking people
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Where
Melbourne, Randwick
Age
18 years and over
People
280 worldwide
Run by
Washington University School of Medicine
See details and how to joinNCT05552157
Phase 2/3Taking people
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Where
Melbourne, Randwick
Age
18 years and over
People
280 worldwide
Run by
Washington University School of Medicine
See details and how to joinNCT06647498
Phase 3Taking people
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
Where
Macquarie Park, Nedlands
Age
55 years to 90 years
People
325 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06947941
No phaseTaking people
Retinal Hyperspectral Imaging in Neurodegenerative Diseases
Where
Melbourne
Age
30 years and over
People
930
Run by
Center for Eye Research Australia
See details and how to joinNCT07545473
Phase 2/3Not yet taking people in Australia
To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease
Where
Bedford Park
Age
50 years to 90 years
People
140
Run by
Benuvia Therapeutics Inc.
See details and how to joinNCT07422311
Phase 2Taking people
Open-label Extension Study in Participants With Early Alzheimer's Disease
Where
Macquarie Park, Nedlands
Age
50 years to 85 years
People
220 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07105709
No phaseTaking people
TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease
Where
Hobart
Age
50 years and over
People
3,000
Run by
University of Tasmania
See details and how to joinNCT05194787